The convergent synthesis of the Lewis A (Le a ) tandem repeat is described. The Le a tandem repeat is a carbohydrate ligand for a mannose binding protein that shows potent inhibitory activity against carcinoma growth. The Le a unit,
Introduction
The Lewis A (Le a ) trisaccharide, {β-D-Gal-(1Ñ3)-[α-L-Fuc-(1Ñ4)]-β-D-GlcNAc}, is a component of glycolipids that have been identified as antigens of the Lewis blood group. Recently, N-linked glycoproteins with Le a tandem repeats ( Figure 1 ) consisting of four or more repeated sequences were isolated from the SW1116 human colorectal carcinoma cell line. This carbohydrate ligand forms a mannose binding protein-carbohydrate complex, which shows potent inhibitory activity against growth of human colorectal carcinoma cells [1] [2] [3] . To elucidate the inhibitory mechanism, it is necessary to determine and synthesize the minimum structure of the carbohydrate ligand; however, synthesis of the Le a tandem repeat has not been reported. We have recently developed and reported a new synthetic strategy for core 2 decasaccharide with four repeated type-II N-acetyllactsamines using a benzyl-protected N-trichloroacetyllactsaminyl imidate with high β-selectivity and high yield [4] . In this paper, we describe a synthetic method for the tetrameric Le a tandem repeat motif and the hexasaccharide and dodecasaccharide, via the synthesis of type-I lactosamine by β-selective galactosylation [5] and convergent synthesis with N-trichloroacetyllactosaminyl imidate. 
Results and Discussion
In the retrosynthetic analysis of the Le a tetramer, we planned the convergent synthesis with a Le a trisaccharide common intermediate, which would be constructed with β-D-Gal-(1→3)-β-D-GlcNTCA synthesized by using β-selective galactosylation and 2-p-methoxybenzyl fucosyl imidate. The trisaccharide was designed as the suitably protected form equipped with TBDPS group on the 1-position of the glucosamine and an allyl group on the 3-position of the galactose for divergent synthesis of the acceptor and the donor. In addition, the trichloroacetyl (TCA) group on the 2-position of the glucosamine and the benzyl groups were expected to ensure high stereoselectivity and high yield during the later glycosylation [4, [6] [7] [8] [9] [10] [11] [12] [13] . We envisioned that the tetramer could be obtained by glycosylation promoted by a catalytic Lewis acid with haxasaccharyl acceptor and donor, which could be prepared from the hexasaccharide Le a dimer, and the hexasaccharide could be synthesized by coupling the acceptor and N-phenyl trichloroacetimidyl donor provided from the Le a trisaccharide common intermediate (Scheme 1).
Le a trisaccharide 11 was synthesized from galactosyl donor 2 [5] , 2-azidoglucosyl acceptor 3 [14] , and fucosyl donor 8 [15, 16] (Scheme 2). First, disaccharide 4 was constructed from 2 and 3 by propionitrile-mediated β-selective galactosylation [5] under BSP-Tf2O-TTBP [17] conditions in 89% yield. Then, 4 was transformed into disaccharide acceptor 7 by reducing the azide group to give 5, TCA group protection to give 6, and reductive ring opening of the benzylidene to give 7 in 79% yield (three steps). The glycosylation of 7 with 8 was conducted in cyclopentyl methyl ether-dichloromethane (1:1) [16, 18] at −40 °C to obtain trisaccharide 9 in 95% yield. Le a common intermediate 11 was provided by deprotection of a 4-methoxybenzyl group and subsequent acetylation.
Le a trisaccharide 11 was readily converted to donor 13 and acceptor 14 (Scheme 3). After desilylation of 11, the resulting hemiacetal 12 was treated with (N-phenyl)trifluoroacetimidoyl chloride [19] and K2CO3 to obtain (N-phenyl)trifluoroacetimidate 13. Acceptor 14 was prepared by selective deallylation with iridium-catalyzed olefin migration, followed by treatment with HgCl2 and HgO in aqueous acetone solution [20] . The glycosylation of 13 and 14 promoted by catalytic TMSOTf proceeded at −78 °C to give hexasaccharide 15 in 93% yield [4, 21, 22] . By using the same procedure, hexasaccharide donor 17 and acceptor 18 were prepared in high yields, respectively. In the next coupling, the oligosaccharides showed lower reactivity, and the reaction occurred at 0 °C to afford dodecasaccharide 19 (88%). Next, the linker for sugar probes was introduced (Scheme 4). Dodecasaccharide 19 was converted to (N-phenyl)trifluoroacetimidate 21 (85% over two steps) in an analogous manner, and coupled with N-Boc aminopropanol to give 22 in 79% yield. After deallylation, microwave-assisted reductive dehalogenation of the TCA group was attempted with excess Zn and AcOH in several solvents (ethyl acetate, 1,4-dioxane, AcOH, and THF) [10] . However, Boc group was cleaved, giving the mixture of aminopropyl and acetamidopropyl derivatives as the main products. It was found that THF was most suitable to obtain aminopropyl derivative 24 almost predominantly. Then, the terminal amino group of 24 was re-protected with Boc group to afford fine 25 in 76% over two steps. 
In the retrosynthetic analysis of the Le a tetramer, we planned the convergent synthesis with a Le a trisaccharide common intermediate, which would be constructed with β-D-Gal-(1Ñ3)-β-D-GlcNTCA synthesized by using β-selective galactosylation and 2-p-methoxybenzyl fucosyl imidate. The trisaccharide was designed as the suitably protected form equipped with TBDPS group on the 1-position of the glucosamine and an allyl group on the 3-position of the galactose for divergent synthesis of the acceptor and the donor. In addition, the trichloroacetyl (TCA) group on the 2-position of the glucosamine and the benzyl groups were expected to ensure high stereoselectivity and high yield during the later glycosylation [4, [6] [7] [8] [9] [10] [11] [12] [13] . We envisioned that the tetramer could be obtained by glycosylation promoted by a catalytic Lewis acid with haxasaccharyl acceptor and donor, which could be prepared from the hexasaccharide Le a dimer, and the hexasaccharide could be synthesized by coupling the acceptor and N-phenyl trichloroacetimidyl donor provided from the Le a trisaccharide common intermediate (Scheme 1).
Le a trisaccharide 11 was synthesized from galactosyl donor 2 [5] , 2-azidoglucosyl acceptor 3 [14] , and fucosyl donor 8 [15, 16] (Scheme 2). First, disaccharide 4 was constructed from 2 and 3 by propionitrile-mediated β-selective galactosylation [5] under BSP-Tf 2 O-TTBP [17] conditions in 89% yield. Then, 4 was transformed into disaccharide acceptor 7 by reducing the azide group to give 5, TCA group protection to give 6, and reductive ring opening of the benzylidene to give 7 in 79% yield (three steps). The glycosylation of 7 with 8 was conducted in cyclopentyl methyl ether-dichloromethane (1:1) [16, 18] at´40˝C to obtain trisaccharide 9 in 95% yield. Le a common intermediate 11 was provided by deprotection of a 4-methoxybenzyl group and subsequent acetylation.
Le a trisaccharide 11 was readily converted to donor 13 and acceptor 14 (Scheme 3). After desilylation of 11, the resulting hemiacetal 12 was treated with (N-phenyl)trifluoroacetimidoyl chloride [19] and K 2 CO 3 to obtain (N-phenyl)trifluoroacetimidate 13. Acceptor 14 was prepared by selective deallylation with iridium-catalyzed olefin migration, followed by treatment with HgCl 2 and HgO in aqueous acetone solution [20] . The glycosylation of 13 and 14 promoted by catalytic TMSOTf proceeded at´78˝C to give hexasaccharide 15 in 93% yield [4, 21, 22] . By using the same procedure, hexasaccharide donor 17 and acceptor 18 were prepared in high yields, respectively. In the next coupling, the oligosaccharides showed lower reactivity, and the reaction occurred at 0˝C to afford dodecasaccharide 19 (88%). Next, the linker for sugar probes was introduced (Scheme 4). Dodecasaccharide 19 was converted to (N-phenyl)trifluoroacetimidate 21 (85% over two steps) in an analogous manner, and coupled with N-Boc aminopropanol to give 22 in 79% yield. After deallylation, microwave-assisted reductive dehalogenation of the TCA group was attempted with excess Zn and AcOH in several solvents (ethyl acetate, 1,4-dioxane, AcOH, and THF) [10] . However, Boc group was cleaved, giving the mixture of aminopropyl and acetamidopropyl derivatives as the main products. It was found that THF was most suitable to obtain aminopropyl derivative 24 almost predominantly. Then, the terminal amino group of 24 was re-protected with Boc group to afford fine 25 in 76% over two steps. (4) . To a mixture of phenyl 3-O-allyl-2,4,6-tri-O-benzyl-1-thio-β-Dgalactopyranoside 2 (438 mg, 0.75 mmol), tert-butyldiphenylsilyl 2-azido-4,6-O-benzylidene-2-deoxy-β-D-glucopyranoside 3 (200 mg, 0.38 mmol), benzenesulfinyl piperidine (237 mg, 1.13 mmol), tri-tert-butylpyrimidine (373 mg, 1.50 mmol), and molecular sieves 4A (1.41 g) in propionitrile (12.5 mL) was added dropwise trifluoromethanesulfonic anhydride (140 μL, 0.83 mmol) at −80 °C under Ar, and stirred for 1 h at −80 °C. The reaction mixture was quenched with sat. NaHCO3 aq., filtered through Celite, and diluted with EtOAc. The organic layer was separated, and the aqueous layer was extracted with EtOAc. The combined organic layer was successively washed with brine, dried over Na2SO4, and concentrated. The crude product was chromatographed on silica gel (PSQ-60B) with toluene-acetone (98:2) to give the title product 4 (338 mg, 89% (5) . A mixture of 4 (576 mg, 0.57 mmol), powdered Zn (1.50 g, 23.0 mmol), and AcOH (0.66 ml, 11.5 mmol) in CH2Cl2 (14 mL) was stirred for 30 min at room temperature under Ar. The mixture was diluted with CHCl3 and filtered through Celite. The filtrate was evaporated, and the residue was diluted with CHCl3. The organic layer was successively washed with sat. NaHCO3, water, and brine, dried over Na2SO4, and concentrated. The residue was chromatographed on silica gel with toluene-MeOH (95:5) to give the title product 5 (540 mg, 96% , tri-tert-butylpyrimidine (373 mg, 1.50 mmol), and molecular sieves 4A (1.41 g) in propionitrile (12.5 mL) was added dropwise trifluoromethanesulfonic anhydride (140 µL, 0.83 mmol) at´80˝C under Ar, and stirred for 1 h at´80˝C. The reaction mixture was quenched with sat. NaHCO 3 aq., filtered through Celite, and diluted with EtOAc. The organic layer was separated, and the aqueous layer was extracted with EtOAc. The combined organic layer was successively washed with brine, dried over Na 2 SO 4 , and concentrated. The crude product was chromatographed on silica gel (PSQ-60B) with toluene-acetone (98:2) to give the title product 4 (338 mg, 89% 
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A mixture of 4 (576 mg, 0.57 mmol), powdered Zn (1.50 g, 23.0 mmol), and AcOH (0.66 ml, 11.5 mmol) in CH2Cl2 (14 mL) was stirred for 30 min at room temperature under Ar. The mixture was diluted with CHCl3 and filtered through Celite. The filtrate was evaporated, and the residue was diluted with CHCl3. The organic layer was successively washed with sat. NaHCO3, water, and brine, dried over Na2SO4, and concentrated. The residue was chromatographed on silica gel with toluene-MeOH (95:5) to give the title product 5 (540 mg, 96% 
A mixture of 4 (576 mg, 0.57 mmol), powdered Zn (1.50 g, 23.0 mmol), and AcOH (0.66 ml, 11.5 mmol) in CH 2 Cl 2 (14 mL) was stirred for 30 min at room temperature under Ar. The mixture was diluted with CHCl 3 and filtered through Celite. The filtrate was evaporated, and the residue was diluted with CHCl 3 . The organic layer was successively washed with sat. NaHCO 3 , water, and brine, dried over Na 2 SO 4 , and concentrated. The residue was chromatographed on silica gel with toluene-MeOH (95:5) to give the title product 5 (540 mg, 96% 
; To a solution of 5 (12.9 g, 13.2 mmol) in pyridine (132 mL) was added dropwise trichloroacetyl chloride (1.76 mL, 15.8 mmol) at 0 °C under Ar, and stirred at 0 °C for 1 h. The mixture was evaporated, and the residue was diluted with CHCl3, successively washed with 2 M HCl, sat. NaHCO3, and brine, dried over Na2SO4, and concentrated. The residue was chromatographed on silica gel with toluene-EtOAc (97:3) to give the title product 6 (14.8 g, quant. 
tert-Butyldiphenylsilyl 3-O-allyl-2,4,6-tri-O-benzyl-β-D-galactopyranosyl-(1→3)-6-O-benzyl-2-deoxy-2-trichloroacetamido-β-D-glucopyranoside (7)
. To a mixture of 6 (814 mg, 0.73 mmol) and molecular sieves 4A (4.20 g) in CH2Cl2 (7.3 mL) was added triethylsilane (463 μL, 2.90 mmol) and trifluoromethane sulfonic acid (127 μL, 1.45 mmol) at −78 °C under Ar, and stirred for 1 h at −78 °C, and 1.5 h at −40 °C. The reaction mixture was quenched with triethylamine, filtered through Celite, and diluted with CHCl3. The organic layer was successively washed with sat. NaHCO3, water, and brine, dried over Na2SO4, and concentrated. The crude product was chromatographed on silica gel with toluene-EtOAc (89:11) to give the title product 7 (665 mg, 82% 
. To a mixture of 6 (814 mg, 0.73 mmol) and molecular sieves 4A (4.20 g) in CH 2 Cl 2 (7.3 mL) was added triethylsilane (463 µL, 2.90 mmol) and trifluoromethane sulfonic acid (127 µL, 1.45 mmol) at´78˝C under Ar, and stirred for 1 h at´78˝C, and 1.5 h at´40˝C. The reaction mixture was quenched with triethylamine, filtered through Celite, and diluted with CHCl 3 . The organic layer was successively washed with sat. NaHCO 3 , water, and brine, dried over Na 2 SO 4 , and concentrated. The crude product was chromatographed on silica gel with toluene-EtOAc (89:11) to give the title product 7 (665 mg, 82% J2, 3 = 10 
To a mixture of 7 (1.96 g, 1.74 mmol), 3,4-di-O-acetyl-2-O-p-methoxybenzyl-L-fucipyranosyl (N-phenyl)-2,2,2-trifluoroacetimidate 8 (1.87 g, 3.47 mmol), and molecular sieves AW-300 (5.22 g) in
To a mixture of 7 (1.96 g, 1.74 mmol), 3, (10) . A solution of 9 (29.3 mg, 19.9 μmol) in trifluoroacetic acid/CH2Cl2 (1:9, 0.80 mL) was stirred for 20 min at room temperature. The reaction mixture was diluted with toluene, and evaporated. The residue was dissolved with CHCl3, successively washed with sat. NaHCO3, water, and brine, dried over Na2SO4, and concentrated. The crude product was chromatographed on silica gel with hexane-EtOAC (80:20) to give the title product 10 (27.0 g, quant. (10) . A solution of 9 (29.3 mg, 19.9 µmol) in trifluoroacetic acid/CH 2 Cl 2 (1:9, 0.80 mL) was stirred for 20 min at room temperature. The reaction mixture was diluted with toluene, and evaporated. The residue was dissolved with CHCl 3 , successively washed with sat. NaHCO 3 , water, and brine, dried over Na 2 SO 4 , and concentrated. The crude product was chromatographed on silica gel with hexane-EtOAC (80:20) to give the title product 10 (27.0 g, quant. 19 (m, 2H, H2C=CHCH2, H-1 ), 5.12-5.10 (m, 2H,  H-1 Fuc , H-4 , PhCH2), 4.68 (d, 1H, PhCH2), 4.53 (d, 1H, PhCH2), 4.47-4.35 (m, 5H, PhCH2 × 4, H-1 Gal ),  4.22-4.11 (m, 3H, H-3 GlcN , H2C=CHCH2 × 2), 3.92 (t, 1H, J3,4 = J4,5 = 9.4 Hz, H-4 GlcN ), 3.85-3.80 (m, 2H,  H-2 Fuc , H-4 Gal ), 3.70-3.56 (m, 4H, H-6a Gal , H-6b Gal , H-6a GlcN , H-2 Gal ), 3.34 (dd, 1H, J5,6a = 4.9 Hz, J5,6b = 8. 7 Hz, H-5 Gal ), 3. 30 (dd, 1H, J2,3 = 9.8 Hz, J3,4 = 2.8 Hz, H-3 Gal ), 3.22-3.19 (m, 2H, H-6b GlcN , H-2 (11) . To a solution of 10 (9.32 g, 6.87 mmol) in pyridine (458 mL) was added acetic anhydride (458 mL) at 0 °C under Ar,
tert-Butyldiphenylsilyl 3-O-allyl-2,4,6-tri-O-benzyl-β-D-galactopyranosyl-(1→3)-[3,4-di-O-acetyl-α-Lfucopyranosyl-(1→4)]-6-O-benzyl-2-deoxy-2-trichloroacetamido-β-D-glucopyranoside
tert-Butyldiphenylsilyl 3-O-allyl-2,4,6-tri-O-benzyl-β-D-galactopyranosyl-(1Ñ3)-[3,4-di-O-acetyl-α-L- fucopyranosyl-(1Ñ4)]-6-O-benzyl-2-deoxy-2-trichloroacetamido-β-D-glucopyranoside
tert-Butyldiphenylsilyl 3-O-allyl-2,4,6-tri-O-benzyl-β-D-galactopyranosyl-(1→3)-[2,3,4-tri-O-acetyl-α-Lfucopyranosyl-(1→4)]-6-O-benzyl-2-deoxy-2-trichloroacetamido-β-D-glucopyranoside
. To a solution of 10 (9.32 g, 6.87 mmol) in pyridine (458 mL) was added acetic anhydride (458 mL) at 0˝C under Ar, and stirred for 7 h at room temperature. The reaction mixture was concentrated. The crude product was chromatographed on silica gel with hexane-EtOAc (67:33) to give the title product 11 (9.45 (12) . To a solution of 11 (1.67 g, 1.19 mmol) in THF (11.9 mL) were added acetic acid (0.68 mL, 11.9 mmol) and 1 M tetra-n-butylammonium fluoride in THF (4.76 mL, 4.76 mmol) at 0 °C under Ar, and stirred for 1 d at room temperature. The reaction mixture was concentrated. The residue was diluted with EtOAc and water, and extracted with EtOAc. The combined organic layer was successively washed with sat. NaHCO3, water, and brine, dried over Na2SO4, and concentrated. The crude product was purified by silica gel column chromatography with hexane-EtOAc (60:40) and gel permeation chromatography (LH-20, CHCl3-MeOH (50:50)) to give the title product 12 (1.38 g, quant. 
3-O-Allyl-2,4,6-tri-O-benzyl-β-D-galactopyranosyl-(1→3)-[2,3,4-tri-O-acetyl-α-L-fucopyranosyl-(1→4)]-6-O-benzyl-2-deoxy-2-trichloroacetamido-D-glucopyranose
. To a solution of 11 (1.67 g, 1.19 mmol) in THF (11.9 mL) were added acetic acid (0.68 mL, 11.9 mmol) and 1 M tetra-n-butylammonium fluoride in THF (4.76 mL, 4.76 mmol) at 0˝C under Ar, and stirred for 1 d at room temperature. The reaction mixture was concentrated. The residue was diluted with EtOAc and water, and extracted with EtOAc. The combined organic layer was successively washed with sat. NaHCO 3 , water, and brine, dried over Na 2 SO 4 , and concentrated. The crude product was purified by silica gel column chromatography with hexane-EtOAc (60:40) and gel permeation chromatography (LH-20, CHCl 3 -MeOH (50:50)) to give the title product 12 (1.38 g, quant. 
3-O-Allyl-2,4,6-tri-O-benzyl-β-D-galactopyranosyl-(1→3)-[2,3,4-tri-O-acetyl-α-L-fucopyranosyl-(1→4)]-6-O-benzyl-2-deoxy-2-trichloroacetamido-D-glucopyranosyl (N-phenyl)-2,2,2-trifuoroacetimidate (13).
A mixture of 12 (1.35 g, 1.16 mmol), (N-phenyl)-2,2,2-trifluoroacetoimidoyl chloride (482 mg, 2.32 mmol), and K2CO3 (802 mg, 5.80 mmol) in acetone (23.2 mL) was stirred for 1 h at room temperature. The reaction mixture was filtered through Celite, and concentrated. The crude product was purified by gel (17) . Compound 16 (97 mg, 42.9 μmol) was reacted with (N-phenyl)-2,2,2-trifluoroacetoimidoyl chloride (17.8 mg, 85.8 μmol) and K2CO3 (29.7 mg, 215 μmol) in acetone (1.7 mL) as described for 13. The crude product was purified by silica gel column chromatography with hexane-EtOAc (83:17) and gel permeation chromatography (19) . To a mixture of the glycosyl donor 17 (276 mg, 113 μmol), the glycosyl acceptor 18 (210 mg, 85.0 μmol), and molecular sieves AW-300 (255 mg) in CH2Cl2 (2.8 mL) was added dropwise TMSOTf (3.0 μL, 17.0 μmol) at 0 °C under Ar, and stirred for 1 h at 0 °C. The reaction mixture was quenched with sat. NaHCO3, filtered through Celite, and diluted with CHCl3. The organic layer was separated, and the aqueous layer was extracted with CHCl3. The combined organic layer was successively washed with brine, dried over Na2SO4, and concentrated. The (19) . To a mixture of the glycosyl donor 17 (276 mg, 113 µmol), the glycosyl acceptor 18 (210 mg, 85.0 µmol), and molecular sieves AW-300 (255 mg) in CH 2 Cl 2 (2.8 mL) was added dropwise TMSOTf (3.0 µL, 17.0 µmol) at 0˝C under Ar, and stirred for 1 h at 0˝C. The reaction mixture was quenched with sat. NaHCO 3 , filtered through Celite, and diluted with CHCl 3 . The organic layer was separated, and the aqueous layer was extracted with CHCl 3 . The combined organic layer was successively washed with brine, dried over Na 2 SO 4 , and concentrated. The crude
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